AzTrials
AzTrials

HIV InfectionsNCT02949713

Text Messaging Plus Motivational Interviewing in Promotion of Breastfeeding Among HIV-infected Women

A study testing Text messaging-motivational interviewing in people with HIV Infections and Breast Feeding, run by University of Stellenbosch at 1 site in South Africa.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary aim of this study is to find out whether it is feasible to conduct a larger study looking at the effect of mobile phone text messaging added to motivational interviewing on number of participants invited to the study who consented to participate and the number with complete evaluation of infant feeding… Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
HIV Infections, Breast Feeding
What is being tested?
Text messaging-motivational interviewing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
1 siteSouth Africa
Study dates
2 May 2019to 13 Aug 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Women living with HIV
  • initiated breastfeeding within 24 hours of giving normal birth
  • on ART
  • 18 years or older
  • ownership of a mobile phone
  • infants judged to be in good health who are discharged soon after delivery

Who cannot join

  • initiating both breastfeeding and formula feeding or formula feeding within 24 hours of giving birth.
  • gave birth to more than one infant
  • birth weight < 2500
  • gestational age < 36 weeks

Trial locations and contacts

1 site in 1 country.

South Africa1 site
  • Moleen Zunza

    Cape Town, Western Cape, 8000

Other trials in South Africa

About this study

Official title: Feasibility and Effects of Mobile Phone Text Messaging Plus Motivational Interviewing Versus Usual Care in Promotion of Breastfeeding Among HIV-infected Women in South Africa: A Randomized, Parallel Group, Controlled Pilot Trial

The primary aim of this study is to find out whether it is feasible to conduct a larger study looking at the effect of mobile phone text messaging added to motivational interviewing on number of participants invited to the study who consented to participate and the number with complete evaluation of infant feeding practices at all study visits.

Secondary aim: In HIV-infected women initiating breastfeeding after giving birth, does interactive weekly mobile phone text messaging plus motivational interviewing versus usual care, improve self-reported adherence to exclusive or any breastfeeding 6 months post-delivery and to determine the number of women remaining in the group they were assigned until end of study or lost to follow-up (protocol adherence).

Read the detailed description

Breastfeeding reduces the risks of dying from infections and is currently recommended as the most beneficial feeding option for infants born to HIV-infected women in low-resourced settings. This recommendation contradicts previous recommendations to avoid breastfeeding to prevent mother-to-child transmission of HIV. South Africa, a high HIV prevalent country, recently phased out access to free formula milk in the public sector in support of breastfeeding for HIV-infected women. The investigators previously found that few HIV-infected South African women choose breastfeeding and among those who did, many stop breastfeeding early. This study involves text messaging breastfeeding advice encouraging women to exclusively breastfeed, and inquire if they have any breastfeeding related problems, and motivational interviews exploring and supporting woman's commitment to continue breastfeeding.Participants meeting inclusion criteria who consent participation will be enrolled by a research nurse and immediately randomly assigned to text messaging plus motivational interviewing group or usual standard of care group.

The investigators propose a randomized, parallel group, standard of care-controlled pilot trial which will be conducted among HIV-infected women of low socio-economic background, giving birth at a primary healthcare clinic in Cape Town, South Africa. The pilot trial will assess the feasibility of conducting a larger trial on communication and support approaches that may improve HIV-infected woman's adherence to exclusive and continued breastfeeding.

Being tested
Text messaging-motivational interviewing
Keywords
HIV, infant feeding, mHealth, behavioural intervention
Medical subject headings
HIV Infections, Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Text messaging-motivational interviewingBehavioural

    Also called mobile phone text messaging, motivational interviewing

    Interactive weekly mobile phone text messaging plus prospective motivational interviews

Study groups in NCT02949713
Study groupRoleWhat they receive
Text messaging-motivational interviewingExperimentalEvery Monday morning, a text message (SMS) will be sent to participants in the intervention group encouraging participants to continue breastfeeding, and inquire if participants have any problems breastfeeding their infants. Participants will be asked to respond within 48 hours, indicating that they either do not have a problem or they have a problem and require help. In addition to text messaging, participants will have motivational interviews post-delivery at weeks 2, 6, and 10. Motivational interviews will explore and support the participant's commitment to continue breastfeeding.
Receives: Behavioral: Text messaging-motivational interviewing
Usual standard of careNo interventionUsual standard of care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants invited to the study who consented to participate.

    Number of participants invited to the study who consented to participate.

    Measured: 6 month post randomization

  2. Number of participants with complete evaluation of infant feeding practices at all study visits

    Number of participants with complete evaluation of infant feeding practices at all study visits as assessed by infant feeding questionnaire.

    Measured: 6 month post randomization

Secondary outcomes (3)
  1. Number of participants remaining in the group they were assigned until end of study or lost to follow-up (protocol adherence).

    Number of participants remaining in the group they were assigned until end of study or lost to follow-up (protocol adherence).

    Measured: 6 month

  2. Number of participants who are exclusively breastfeeding

    Number of participants who report giving only breast milk and no other liquids or solid based foods to their infants as assessed by the infant feeding questionnaire

    Measured: 6 month post randomization

  3. Number of participants who are breastfeeding

    Number of participants who report giving breast milk and other liquids or solid based foods to their infants as assessed by the infant feeding questionnaire.

    Measured: 6 month post randomization

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2016 (estimated)
  2. Study start2 May 2019
  3. Primary completion13 Aug 2020
  4. Study completion13 Aug 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
52 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02949713
Sponsor's protocol ID
N16/09/11
Status last verified
Sep 2023
First submitted
26 Oct 2016
Last updated
26 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The IPD will be available from the corresponding author on reasonable request

Publications

  • Zunza M, Young T, Cotton M, Slogrove A, Mbuagbaw L, Kuhn L, Thabane L. Evaluating interactive weekly mobile phone text messaging plus motivational interviewing for breastfeeding promotion among women living with HIV, giving normal birth at a primary healthcare facility in South Africa: a feasibility randomised controlled trial. BMJ Open. 2023 Oct 10;13(10):e073385. doi: 10.1136/bmjopen-2023-073385.

    PubMed 37816561
  • Zunza M, Cotton MF, Mbuagbaw L, Lester R, Thabane L. Interactive weekly mobile phone text messaging plus motivational interviewing in promotion of breastfeeding among women living with HIV in South Africa: study protocol for a randomized controlled trial. Trials. 2017 Jul 17;18(1):331. doi: 10.1186/s13063-017-2079-0.

    PubMed 28716146

Questions about this trial

What is this clinical trial studying?

A study testing Text messaging-motivational interviewing in people with HIV Infections and Breast Feeding, run by University of Stellenbosch at 1 site in South Africa.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Africa. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants invited to the study who consented to participate. (time frame: 6 month post randomization). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02949713, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in